Skip to main content

Table 3 Clinical findings in healthy and diabetic children

From: Urinary N-Acetyl-β-D glucosaminidase (uNAG) levels as an early marker for diabetic nephropathy in children with type 1 diabetes

Clinical findings

Diabetics

Group 3

(Control)

n = 30

P value

Group 1

n = 30

Group 2

n = 30

Systolic blood pressure (mmHg)

108 ± 6.5

111 ± 6.7

108 ± 6.2

0.25

Diastolic blood pressure (mmHg)

70 ± 4.4

75 ± 3.8

69 ± 5.1

< 0.001*

Respiratory rate (cycle/min)

20 ± 1.7

19 ± 1.6

21 ± 1.5

0.03*

Heart rate (bpm)

99 ± 6.5

94 ± 6.3

94 ± 5.6

0.003*

Cardiac examination,

 High S1

0 (0)

0 (0)

2 (7)

0.10

 Murmur

0 (0)

0 (0)

1 (30)

 Normal

30 (100)

30 (100)

27 (90)

Chest examination

 Rhonchi

2 (7)

2 (7)

3 (10)

0.2

 Crepitation

1 (3)

6 (20)

1 (3)

 Normal

27 (90)

22 (73)

26 (87)

Abdominal examination

 Tenderness

1 (3)

6 (20)

0 (0)

0.001*

 Distension

4 (13)

0 (0)

0 (0)

 Normal

25 (83)

24 (80)

30 (100)

Neurologic examination

 Neuropathy

11 (37)

12 (40)

0 (0)

< 0.001*

 Normal

19 (63)

18 (60)

30 (100)

Tanner stage

 T1

1 (3)

9 (30)

9 (30)

0.4

 T2

4 (13)

14 (47)

18 (60)

 T3

2 (7)

7 (23)

3 (10)

  1. Data were presented as mean ± standard deviation, number (percentage)
  2. *Significant as p value < 0.05